Precigen Inc
Company Profile
Business description
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Contact
20374 Seneca Meadows Parkway
GermantownMD20876
USAT: +1 301 556-9900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
25
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,480.40 | 17.80 | 0.21% |
CAC 40 | 7,743.75 | 49.31 | 0.64% |
DAX 40 | 23,499.32 | 146.63 | 0.63% |
Dow JONES (US) | 41,249.38 | 119.07 | -0.29% |
FTSE 100 | 8,554.80 | 23.19 | 0.27% |
HKSE | 23,079.88 | 212.14 | 0.93% |
NASDAQ | 17,928.92 | 0.78 | 0.00% |
Nikkei 225 | 37,522.79 | 19.46 | 0.05% |
NZX 50 Index | 12,645.86 | 40.79 | 0.32% |
S&P 500 | 5,659.91 | 4.03 | -0.07% |
S&P/ASX 200 | 8,250.40 | 19.20 | 0.23% |
SSE Composite Index | 3,354.53 | 12.53 | 0.37% |